| Literature DB >> 16895601 |
Danilo Arnone1, Anish Patel, Giles Ming-Yee Tan.
Abstract
BACKGROUND: Folie à Deux is a rare syndrome that has attracted much clinical attention. There is increasing doubt over the essence of the condition and the validity of the original description, such that it remains an elusive entity difficult to define.Entities:
Year: 2006 PMID: 16895601 PMCID: PMC1559622 DOI: 10.1186/1744-859X-5-11
Source DB: PubMed Journal: Ann Gen Psychiatry ISSN: 1744-859X Impact factor: 3.455
Lasègue-Falret syndrome
| A syndrome prevalent among women living more or less confined, marked by: |
| Coincidental appearance of psychotic symptoms in members of a family while living together |
| Appearance of psychotic symptoms in two closely associated persons |
| Transmission of psychotic symptoms from a sick person to one person or several healthy individuals who elaborate on the induced delusions |
Figure 1Demographic Characteristics, Family and Psychiatric History. Difference in age between primary and secondary: (#) not statistically significant difference; (##): χ2 = 7.51, df = 26, p > 0.05. Difference in gender in the primaries: (*) χ2 alpha = 0.005 df = 1 and (§) χ2 = 4.67, df = 1, p > 0.05. Difference in gender in the secondaries: (**) χ2 alpha = 0.05 df = 1 and (§§) χ2 = 4.67, df = 1, p > 0.05. Difference in family history between primaries and secondaries: (¤)χ2 = 0.84, df = 1, p = 0.359. Difference in past psychiatric history between primaries and secondaries: (¶) χ2 = 1.67, df = 1, p = 0.196. NS = Not stated.
The nature of the relationship
| Husband:Wife | 10 (16.4) | 12 (28.6) |
| Wife:Husband | 8 (13.1) | 10 (23.8) |
| Parent:Child | 19 (31.1) | 6 (7.1) |
| Child:Parent | 0 | 2 (4.2) |
| Siblings | 18 (29.5), 3 Twins | 11 (26.2), 5 Twins (all F) (Sisters = 10, Brothers = 1) |
| Friends | 6 (9.9) | 1 (2.4) |
Risk factors, duration of the association, and exposure in the dyad
| 61 (100) | 42 (100) | |
| Social Isolation: 53 (84) | Social Isolation 27 (64.3) | |
| Others in the secondaries: NS | Others in the secondaries: | |
| Secondary passive 5 (5.9) | ||
| Cognitive impairment 3 (3.5) | ||
| Language difficulties 1 (1.2) | ||
| Life events 1 (1.2) | ||
| 47 (77.0) | 32 (52.4) | |
| NS (NS) 3–948 | 30.7 (19.07), 0.5–81.00 | |
| NS | 35 (57.4) | |
| NS | 72.98 (86.46), 0.00–336.00 |
NS: Not stated
Diagnosis, co-morbidity and psychopathology
| 54(88.5) | 54 (88.5) | 58 (95.0) | |
| Schizophrenia 24 (44.4) | Delusions: | Hallucinations: | |
| Mood disorders 7 (13.0) | Persecutory 46 (75.4) | Type clearly described 30 (52.6) | |
| Delusional disorders 6 (11.1) | Grandiose 8 (13.1) | Not sufficient data 18 (47.4) | |
| Pure Shared delusional disorder 54 (88.5) | Delusions: | Hallucinations: | |
| Co-morbidity 48 (89.0): | No difference in type or quality reported. | Same type but less intense quality 17 (29.3) | |
| Dementia | Only in the secondary 2 (3%) | ||
| Depression | No sufficient data 39 (67.0) | ||
| Mental retardation | |||
| 45 (100) | 53 (87) | 25 (59.5%) | |
| Delusional disorder 15 (33.3) | Delusions: | Hallucinations: | |
| Schizophrenia 13 (28.9) | Persecution 30 (35.3) | Auditory 11 (45.8) | |
| Pure Induced delusional disorder 30 (71.4) | Delusions: | Hallucinations: |
(*) Haptic hallucinations.
Treatment options
| 5 (11.9) | 8 (19.0%) | |
| 14 (33.3) | 13 (30.9) | |
| 30 (71.4) | 26 (61.9) | |
| Antipsychotics 15 (35.7) | Antipsychotics 9 (21.4) | |
| Antidepressants 1 (2.4) | Antidepressants 2 (4.8) | |
| Non specified 14 (33.3) | Non specified 15 (35.7) | |
| 5 (11.9) | 2 (4.8) | |
| Mood stabilisers/antipsychotics 4 (9.5) | Mood stabilisers/antipsychotics 2 (4.8) | |
| Antidepressants/antipsychotics 1 (2.4) | ||
| 2 (4.8) | 6 (14.3) | |
| 1 (2.4) | 0 (0) | |
| 0 (0) | 1 (2.4)* |
(*) Cardio conversion
Treatment settings
| 26 (61.9) | 22 (52.4) | |
| 4 (9.5) | 7 (16.6) | |
| 4 (9.5) | 4 (9.5) | |
| 1 (2.4) | 1 (2.4) |